Ashenafi Y. Tilahun

780 total citations
24 papers, 597 citations indexed

About

Ashenafi Y. Tilahun is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ashenafi Y. Tilahun has authored 24 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 8 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Ashenafi Y. Tilahun's work include Immune Response and Inflammation (12 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and T-cell and B-cell Immunology (7 papers). Ashenafi Y. Tilahun is often cited by papers focused on Immune Response and Inflammation (12 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and T-cell and B-cell Immunology (7 papers). Ashenafi Y. Tilahun collaborates with scholars based in United States, South Korea and Singapore. Ashenafi Y. Tilahun's co-authors include Govindarajan Rajagopalan, Chella S. David, Robin Patel, Vaidehi Chowdhary, Eric Marietta, Melissa J. Karau, Tsung Teh Wu, Yogish C. Kudva, Andrés Gómez and Carl J. Yeoman and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ashenafi Y. Tilahun

24 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashenafi Y. Tilahun United States 15 305 167 166 101 67 24 597
Alejandro Francisco‐Cruz United States 13 152 0.5× 103 0.6× 141 0.8× 156 1.5× 93 1.4× 35 517
Lingadakai Ramachandra India 15 206 0.7× 101 0.6× 214 1.3× 37 0.4× 79 1.2× 30 717
M. Jubayer Rahman United States 14 365 1.2× 157 0.9× 284 1.7× 64 0.6× 112 1.7× 20 815
Ippei Sakamaki Japan 12 293 1.0× 261 1.6× 171 1.0× 170 1.7× 79 1.2× 48 746
Yun Pang China 9 201 0.7× 170 1.0× 215 1.3× 26 0.3× 32 0.5× 13 554
Florence Deknuydt France 9 564 1.8× 167 1.0× 139 0.8× 96 1.0× 179 2.7× 11 922
Rebecca Fine United States 6 173 0.6× 102 0.6× 334 2.0× 34 0.3× 65 1.0× 8 545
Pamela Stein Germany 14 326 1.1× 57 0.3× 86 0.5× 40 0.4× 51 0.8× 19 506
Mayuko Tamura Japan 10 261 0.9× 52 0.3× 140 0.8× 226 2.2× 79 1.2× 26 639
Andrea P. Martin United States 13 639 2.1× 85 0.5× 202 1.2× 247 2.4× 126 1.9× 19 1.0k

Countries citing papers authored by Ashenafi Y. Tilahun

Since Specialization
Citations

This map shows the geographic impact of Ashenafi Y. Tilahun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashenafi Y. Tilahun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashenafi Y. Tilahun more than expected).

Fields of papers citing papers by Ashenafi Y. Tilahun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashenafi Y. Tilahun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashenafi Y. Tilahun. The network helps show where Ashenafi Y. Tilahun may publish in the future.

Co-authorship network of co-authors of Ashenafi Y. Tilahun

This figure shows the co-authorship network connecting the top 25 collaborators of Ashenafi Y. Tilahun. A scholar is included among the top collaborators of Ashenafi Y. Tilahun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashenafi Y. Tilahun. Ashenafi Y. Tilahun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tracy, Sean, et al.. (2022). Proteomic and Transcriptomic Profiling Reveals Insights into Mechanisms of Leukemic Immune Escape. Blood. 140(Supplement 1). 6341–6342. 2 indexed citations
2.
Mullins, Stefanie, John P. Vasilakos, Katharina Deschler, et al.. (2019). Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies. Journal for ImmunoTherapy of Cancer. 7(1). 244–244. 137 indexed citations
3.
Fakhari, Amir, James Elvecrog, John P. Vasilakos, et al.. (2017). Thermosensitive Gel–Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197. Journal of Pharmaceutical Sciences. 106(8). 2037–2045. 23 indexed citations
5.
Kim, Choon Kwan, Melissa J. Karau, Kerryl E. Greenwood‐Quaintance, et al.. (2015). Superantigen-Producing Staphylococcus aureus Elicits Systemic Immune Activation in a Murine Wound Colonization Model. Toxins. 7(12). 5308–5319. 19 indexed citations
6.
Chowdhary, Vaidehi, Chao Dai, Ashenafi Y. Tilahun, et al.. (2015). A Central Role for HLA-DR3 in Anti-Smith Antibody Responses and Glomerulonephritis in a Transgenic Mouse Model of Spontaneous Lupus. The Journal of Immunology. 195(10). 4660–4667. 15 indexed citations
7.
Chung, Jin-Won, Kerryl E. Greenwood‐Quaintance, Melissa J. Karau, et al.. (2015). Superantigens produced by catheter-associated Staphylococcus aureus elicit systemic inflammatory disease in the absence of bacteremia. Journal of Leukocyte Biology. 98(2). 271–281. 7 indexed citations
8.
Kim, Choon Kwan, Melissa J. Karau, Kerryl E. Greenwood‐Quaintance, et al.. (2014). Superantigens in Staphylococcus aureus isolated from prosthetic joint infection. Diagnostic Microbiology and Infectious Disease. 81(3). 201–207. 6 indexed citations
9.
Tilahun, Ashenafi Y., Vaidehi Chowdhary, Chella S. David, & Govindarajan Rajagopalan. (2014). Systemic Inflammatory Response Elicited by Superantigen Destabilizes T Regulatory Cells, Rendering Them Ineffective during Toxic Shock Syndrome. The Journal of Immunology. 193(6). 2919–2930. 20 indexed citations
10.
Chung, Jin-Won, Melissa J. Karau, Kerryl E. Greenwood‐Quaintance, et al.. (2014). Superantigen profiling of Staphylococcus aureus infective endocarditis isolates. Diagnostic Microbiology and Infectious Disease. 79(2). 119–124. 15 indexed citations
11.
Marietta, Eric, Andrés Gómez, Carl J. Yeoman, et al.. (2013). Low Incidence of Spontaneous Type 1 Diabetes in Non-Obese Diabetic Mice Raised on Gluten-Free Diets Is Associated with Changes in the Intestinal Microbiome. PLoS ONE. 8(11). e78687–e78687. 98 indexed citations
12.
Tilahun, Ashenafi Y., et al.. (2012). The impact of tacrolimus on the immunopathogenesis of staphylococcal enterotoxin-induced systemic inflammatory response syndrome and pneumonia. Microbes and Infection. 14(6). 528–536. 18 indexed citations
13.
Chowdhary, Vaidehi, et al.. (2012). Chronic Exposure to Staphylococcal Superantigen Elicits a Systemic Inflammatory Disease Mimicking Lupus. The Journal of Immunology. 189(4). 2054–2062. 39 indexed citations
14.
Tilahun, Mulualem E., Alan C. Kwan, Kannan Natarajan, et al.. (2011). Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEB. PLoS ONE. 6(11). e27203–e27203. 12 indexed citations
15.
Tilahun, Ashenafi Y., et al.. (2011). Interferon Gamma-Dependent Intestinal Pathology Contributes to the Lethality in Bacterial Superantigen-Induced Toxic Shock Syndrome. PLoS ONE. 6(2). e16764–e16764. 35 indexed citations
16.
Tilahun, Ashenafi Y., Eric Marietta, Tsung Teh Wu, et al.. (2011). Human Leukocyte Antigen Class II Transgenic Mouse Model Unmasks the Significant Extrahepatic Pathology in Toxic Shock Syndrome. American Journal Of Pathology. 178(6). 2760–2773. 24 indexed citations
17.
Rajagopalan, Govindarajan, Ashenafi Y. Tilahun, Koji Iijima, et al.. (2011). HLA‐DR polymorphism modulates response to house dust mites in a transgenic mouse model of airway inflammation. Tissue Antigens. 77(6). 589–592. 8 indexed citations
18.
Tilahun, Ashenafi Y., et al.. (2010). Detrimental Effect of the Proteasome Inhibitor, Bortezomib in Bacterial Superantigen- and Lipopolysaccharide-induced Systemic Inflammation. Molecular Therapy. 18(6). 1143–1154. 18 indexed citations
19.
Rajagopalan, Govindarajan, Ashenafi Y. Tilahun, Yan W. Asmann, & Chella S. David. (2009). Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor. Physiological Genomics. 37(3). 279–293. 15 indexed citations
20.
Rajagopalan, Govindarajan, Yan W. Asmann, Ashenafi Y. Tilahun, et al.. (2008). CYCLOOXYGENASE 2 PATHWAY AND ITS THERAPEUTIC INHIBITION IN SUPERANTIGEN-INDUCED TOXIC SHOCK. Shock. 30(6). 721–728. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026